Posts tagged: GlaxoSmithKline

GlaxoSmithKline splashes out $1.4 billion on Aiolos Bio, Inc

Tuesday, 9 January 2024, 7:49 am

Another day, another biopharmaucetical takeover by a major pharmaceutical company.

This time it's the turn of FTSE 100-listed GlaxoSmithKline, which is paying $1.4 billion for Aiolos Bio, Inc, a clinical-stage biopharmaceutical company developing treatments for respiratory and inflammatory conditions.

Below is the link to this morning if you would like to read all the details of the transaction:..


Deals, Deals, Deals ... in a bear market - Part 45

Tuesday, 18 April 2023, 8:20 am

New deals are being announced on a daily basis at the moment, with the pharmaceutical sector one of the most buoyant for dealmaking.

The latest deal is GlaxoSmithKline's takeover of Canadian biopharmaceutical company Bellus Health for $14.75 a share or around £1.6 billion.

That price is double Bellus Health's closing price of $7.26!

Below is a link to the press release if you want to read all the detail of the deal:..


Canaccord Genuity's Quest bullish about takeover deals ... - Part 4

Wednesday, 11 January 2023, 2:14 pm

It's that time of the year when scribblers at Canaccord Genuity's Quest release a note with their UK M&A takeover tips - all 94 of them.

Graham Simpson who compiled this list of of potential takeover targets, writes: "UK companies continue to look materially undervalued, potentially making them takeover targets for both private equity and international corporates."..


Betaville Intelligence

RARE ALERT: GlaxoSmithKline said to ... - Part 5

Tuesday, 22 March 2022, 4:24 pm

The European-based investor group seeking to persuade the board of Aurinia Pharmaceuticals to carry out a strategic review has appointed a US lawyer to manage an action group for other investors looking to back its activist campaign.

The move comes as the investment consortium, led by the Switzerland-based MKT Tactical Fund, recently wrote a second letter to the chairman of Aurinia, George Milne Junior...


GlaxoSmithKline said to be eyeing £1 billion plus takeover bid for Theravance Biopharma, reports The Times

Friday, 11 February 2022, 8:21 am

Has GlaxoSmithKline truly given up its pursuit of Aurinia Pharmaceuticals, the US-listed drug developer?

Last year Betaville Intelligence reported that GSK was one of the pharmaceutical giants circling Aurinia but now The Times is reporting the FTSE 100-listed group is looking at a different takeover target...


Unilever may be a target for activist such as Nelson Peltz, reports FT - Part 3

Sunday, 23 January 2022, 12:37 pm

The Unilever might be a target for Nelson Peltz theory was first aired last summer but now it appears to be have become fact.

Indeed, hacks at the venerable Financial Times have dug a decent scoop today about Peltz building a stake after the botched £50 billion tilt GlaxoSmithKline's consumer division. Below is a link to the FT piece:..


Unilever bids £50 billion for GlaxoSmithKline's consumer arm, reveals The Sunday Times - Part 2

Monday, 17 January 2022, 9:57 pm

Well, it looks like Ian "Kingy" King is first out of the traps to highlight something little old Betaville had been ruminating on with an old City contact over a few glasses down the pub this evening.

In a piece today King, a former City editor of The Times and now business presenter at Sky News, argues Unilever may have accidently put itself in play after attempting to buy GlaxoSmithKline's consumer division for £50 billion. Below is the link:..